Oslo, 9 September 2022, Ultimovacs ASA (the “Company”) refers to the announcement published on 5 September 2022 regarding the issuance of new shares in connection with the Company’s employee incentive program.
The share capital increase related to the share issue of 44,000 new shares has been registered in the Norwegian Register of Business Enterprises, and the Company’s new share capital is NOK 3,426,576.10, divided into 34,265,761 shares, each with a par value of NOK 0.10.
For further information, please contact:
Jónas Einarsson, Chairman of the Board of Directors of Ultimovacs ASA
Phone: +47 480 96 355
Carlos de Sousa, CEO
Phone: +47 908 92507
Hans Vassgård Eid, CFO
Phone: +47 482 48632